Patients with rheumatoid arthritis (RA) are more prone to diabetes than the general population, leading to an elevated risk of cardiovascular disease. A study featured …
A recent study published in Annals of the Rheumatic Diseases has reported a better clinical remission rate for abatacept and certolizumab pegol than active conventional …
In a recent review article published in the journal Nutrients, researchers explored the potential of herbs and spices as adjuvant treatments for rheumatic diseases (RD). …
In a randomized controlled trial published in JAMA Network Open, it was found that the effectiveness of tofacitinib is comparable to adalimumab for treating rheumatoid …
According to a phase 2a study published in New England Journal of Medicine, peresolimab has shown effectiveness in rheumatoid arthritis (RA) patients. Peresolimab is a …
Stem cell therapy has shown promising results in the treatment of arthritis, with the positive outcomes mainly attributed to the anti-inflammatory properties of mesenchymal stem …
According to recent research published in the Annals of Rheumatic Diseases, patients with immune checkpoint inhibitor-associated inflammatory arthritis (ICI-IA) who are treated with biologic disease-modifying …
Recently, the findings of the international ASCORE study published in Clinical Rheumatology found that the 2-year retention rate for subcutaneous (SC) abatacept was 47%, accompanied …
Despite the recent therapeutic advances, nearly 25% of patients are refractory to the treatment regimens. The findings of an international multi-centre study led by MedUni …